Remitly Insiders Sell $6M as Stock Trails Analyst Targets

NEW YORK, May 24 —

Remitly Global beat Wall Street earnings estimates in each of the past three quarters. Trailing twelve-month revenue grew 25.2% to $1.73 billion. The stock trades near $21.58, roughly 28% below the analyst consensus price target. In that same 90-day window surrounding the Q1 beat, at least six insiders filed Forms 4 documenting $5.97 million in open-market sales and zero purchases.

Three Beats Running

The Q1 2026 beat was real but narrow: EPS of $0.19 against a $0.18 consensus estimate per the company's May 6 8-K. The prior quarter produced a similar narrow beat. Two quarters back, the margin was wider: $0.39 against a $0.16 estimate, more than double what analysts expected. Three consecutive beats point to something durable, even as the margin has narrowed.

Below the EPS line, the numbers hold up. Revenue grew 25.2% to $1.73 billion on a trailing basis. Gross margin sits at 60.8%. Free cash flow totaled $182 million over the trailing twelve months. At 13.1x forward earnings, the stock is cheap relative to that growth rate. The financial case for Remitly is straightforward.

One Direction Only

Then there is the insider ledger. Over the trailing 90 days, at least six Remitly insiders filed Forms 4 documenting open-market sales totaling $5.97 million. Open-market purchases in the same period: zero.

The asymmetry matters more than the dollar total. Insider selling has many legitimate explanations: estate planning, diversification, margin calls, vesting schedules. An insider who buys shares in the open market, with after-tax personal capital, at the prevailing price sends one message: the person closest to the business thinks it is worth more. Nineteen or more documented transactions totaled $5.97 million in outflows over 90 days. Not one of six or more filers bought a share. The signal runs in one direction.

Eleven Sales, One Director

Director Joshua Hug's Form 4 record stands out for its persistence. Per SEC filings, Hug executed at least 11 separate open-market sales between April 14 and May 15, 2026, at prices ranging from $17.76 to $24.89 per share. The 31-day span rules out a one-time liquidity event. The nearly 40% spread between the low and high transaction prices shows the selling was not tied to hitting a specific target. Hug sold at $17.76 — below where the stock trades today — and kept selling through $24.89. Eleven transactions in 31 days is a program, not a decision.

The CPTO's Timing

The single largest transaction in the filing record came from Chief Product and Technology Officer Ankur Sinha. On May 14, 2026, eight days after Remitly filed its Q1 earnings results with the SEC, Sinha sold 50,000 shares at $23.42 per share for total proceeds of $1.17 million per his Form 4 filing.

The timing matters. Insider trading windows typically open after an earnings release, giving officers a clear period to transact on public information. Sinha's sale came within that window. A CPTO has direct visibility into product velocity and technology costs. His decision to sell 50,000 shares eight days after the company beat estimates is not disqualifying. It runs against the idea that management is optimistic about where the stock is headed.

What Needs to Be True

A forward P/E of 13.1x for a company growing revenue at 25% with a 60.8% gross margin and $182 million in trailing free cash flow is cheap if the growth rate holds. Three consecutive earnings beats support that argument. The stock sits 28% below the analyst consensus target. That gap either means analysts are too optimistic or the stock is underpriced.

The breadth of insider activity shifts the balance toward caution. Not one officer or director added shares over 90 days, against $5.97 million in documented sales across six or more insiders. That does not invalidate the financial case. It prevents a high-conviction bullish call.

The next test is Q2 2026 earnings. A fourth consecutive beat suggests analysts have been underestimating Remitly and the gap to the consensus target will close. A miss reframes the insider activity as a forward signal rather than coincidental liquidity management. Until then, the financial fundamentals and the Form 4 filings point in opposite directions, and both deserve weight.

Run the free Remitly Global, Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Is Remitly stock a buy right now?

Remitly's financials — 25.2% revenue growth, a 60.8% gross margin, $182M in trailing FCF, and a 13.1x forward P/E — support a constructive view. However, $5.97 million in insider selling with zero open-market purchases over 90 days introduces enough uncertainty to warrant a neutral rather than bullish stance until Q2 earnings provide a cleaner read.

Why are Remitly insiders selling stock?

Per SEC Form 4 filings, at least six insiders including CPTO Ankur Sinha and Director Joshua Hug sold shares between April and May 2026. Insider sales can reflect diversification or personal financial planning, but the aggregate $5.97M in sales with zero offsetting purchases across 19 or more transactions is a uniformly one-directional pattern that is difficult to dismiss.

Did Remitly beat Q1 2026 earnings estimates?

Yes. Remitly reported Q1 2026 EPS of $0.19, beating the $0.18 consensus estimate, per the company's May 6, 2026 8-K filing with the SEC. The quarter marked the third consecutive period in which Remitly exceeded analyst expectations.

What is Remitly's revenue growth rate?

Remitly's trailing twelve-month revenue reached $1.73 billion as of the most recent reported period, representing 25.2% year-over-year growth. The company also posted a 60.8% gross margin and $182 million in trailing free cash flow alongside that top-line expansion.

Who sold Remitly shares in 2026?

Among the documented sellers per Form 4 filings: CPTO Ankur Sinha sold 50,000 shares on May 14, 2026 for $1.17 million, eight days after Q1 earnings; Director Joshua Hug executed at least 11 separate sales between April 14 and May 15, 2026 at prices ranging from $17.76 to $24.89. At least four other insiders also filed open-market sales in the same 90-day window.